US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Qudian Inc.

2.72

-0.0100-0.37%

Volume:459.85K

Turnover:1.25M

Market Cap:449.14M

PE:39.71

High:2.76

Open:2.71

Low:2.66

Close:2.73

Loading ...

Overview Company News Filings

INCY Stock Down on Disappointing Skin Disease Study Data

ZJK Industrial Showcases Advanced Quick Disconnect Components at NVIDIA’s GTC25 Conference

Geneva-based SGS Certifies Samsung Electronics' QD TV Sheet as Cadmium-Free

MT Newswires Live

Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension

Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress

Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress

February 2025's Top US Penny Stocks To Watch

Simply Wall St.

Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

QD Laser, Inc. Reports Mixed Financial Results Amid Sales Growth

QD Laser 9-Mos Parent Loss Y328.00M Vs Loss Y369.00M

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium

Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance

Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting

Qudian Inc. Announces Appointment of Auditor

THOMSON REUTERS

Qudian Inc. Announces Appointment of Auditor

3 Promising Penny Stocks On US Exchanges In January 2025

Simply Wall St.

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QD/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","market":"US","secType":"STK","nameCN":"Qudian Inc.","latestPrice":2.72,"timestamp":1746043200000,"preClose":2.73,"halted":0,"volume":459846,"delay":0,"floatShares":121000000,"shares":165126492,"eps":0.068502,"marketStatus":"Pre-Mkt","change":-0.01,"latestTime":"05-01 08:16:31 EDT","open":2.71,"high":2.755,"low":2.66,"amount":1254747.521673,"amplitude":0.034799,"askPrice":2.99,"askSize":100,"bidPrice":2.29,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.068502,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746106200000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1508299200000,"exchange":"NYSE","adjPreClose":2.72,"postHourTrading":{"tag":"盘后","latestPrice":2.72,"preClose":2.72,"latestTime":"18:46 EDT","volume":2,"amount":5.35,"timestamp":1746053194763},"volumeRatio":1.1128605542521424,"impliedVol":0.9848,"impliedVolPercentile":0.8193},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QD\",,,,,undefined,":{"symbol":"QD","floatShares":121000000,"roa":"-1.62%","roe":"0.80%","lyrEps":0.068728,"volumeRatio":1.1128605542521424,"shares":165126492,"dividePrice":0,"high":2.755,"amplitude":0.034799,"preClose":2.73,"low":2.66,"week52Low":1.52,"pbRate":"0.29","psRate":"15.10","week52High":3.34,"institutionHeld":0,"latestPrice":2.72,"eps":0.068502,"divideRate":0,"volume":459846,"delay":0,"ttmEps":0.068502,"open":2.71,"prevYearClose":2.82,"prevWeekClose":2.65,"prevMonthClose":2.72,"prevQuarterClose":2.69,"fiveDayClose":2.63,"twentyDayClose":2.65,"sixtyDayClose":2.76},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QD\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520089932","title":"INCY Stock Down on Disappointing Skin Disease Study Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2520089932","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520089932?lang=en_us&edition=fundamental","pubTime":"2025-03-19 03:00","pubTimestamp":1742324400,"startTime":"0","endTime":"0","summary":"Shares of Incyte INCY were down 8.62% on Monday after the announcement of data from two late-stage studies on an oral small-molecule JAK1 inhibitor, povorcitinib, for the treatment of hidradenitis suppurativa .HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.While both the late studies STOP-HS1 and STOP-HS2 studies met their primary endpoint, the results lagged investor expectations, and consequently, shares declined.Povorcitinib is an oral small-molecule JAK1 selective inhibitor currently in phase III studies for HS, vitiligo and prurigo nodularis , as well as phase II trials for asthma and chronic spontaneous urticaria .The phase III studies STOP-HS1  and STOP-HS2  are evaluating the efficacy and safety of povorcitinib in adult patients with moderate to severe HS. Both studies include a 12-week double-blind, placebo-controlled treatment period, followed by a 42-week extension period and 30-day safety follow-up.Data from the STOP-HS2 study s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/incy-stock-down-disappointing-skin-190000520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1066051498.USD","BK4583","AN","LU1571399168.USD","BK4166","BMRN","LU0234570918.USD","IE00B19Z3581.USD","LU0058720904.USD","LU2087621335.USD","IE0002270589.USD","BK4503","GSK.UK","IE00B3T34201.USD","BK4139","LU1169589451.USD","IE00BKVL7J92.USD","LU0109394709.USD","BK4568","QD","IE00B19Z3B42.SGD","BK4550","BK4578","LU0289739699.SGD","INCY","IE00B7SZLL34.SGD","LU1829250122.USD","LU1169590202.USD","BK4563","BK4585","GILD","BK4588","IE00BSNM7G36.USD","BK4532","BK4566","LU0889565916.HKD","LU1430594728.SGD","LU1585245621.USD","PN","LU1066053197.SGD","BK4007","LU0320765992.SGD","LU1839511570.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU2468319806.SGD","GSK","BK4214"],"gpt_icon":0},{"id":"2520244335","title":"ZJK Industrial Showcases Advanced Quick Disconnect Components at NVIDIA’s GTC25 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2520244335","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520244335?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:25","pubTimestamp":1742217900,"startTime":"0","endTime":"0","summary":"Shenzhen, China, March  17, 2025  (GLOBE NEWSWIRE) -- ZJK Industrial Co. Ltd. (NASDAQ: ZJK) (“ZJK Industrial”, “ZJK” or the “Company”), a high-tech precision parts and hardware manufacturer for artifi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/17/3043798/0/en/ZJK-Industrial-Showcases-Advanced-Quick-Disconnect-Components-at-NVIDIA-s-GTC25-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242650005.HKD","LU1066051498.USD","LU1623119135.USD","LU0079474960.USD","NVDA","LU2413666426.HKD","NVDS","LU2125909916.SGD","LU1127390331.HKD","LU1923622291.USD","QD","NVDY","NVD3.UK","LU2360032135.SGD","SNVD.UK","LU1242518931.SGD","NVDD","LU2063271972.USD","LU0965508806.USD","NVDU","IE00BYXW3230.USD","2NVD.UK","LU1712237335.SGD","IE0004445015.USD","3NVD.UK","LU0265550946.USD","LU0979878070.USD","LU1066051811.HKD","LU0107464264.USD","LU2125909759.SGD","NVDS.UK","IE00B3M56506.USD","LU2125154935.USD","LU2211815571.USD","NVIW.SI","LU1066053197.SGD","ZJK","LU0417517546.SGD","IE00B775H168.HKD","LU1923622614.USD","NVD2.UK","IE0004091025.USD","AEIS","IE00BJJMRX11.SGD","LU1861127337.USD","CNC","LU0964807845.USD"],"gpt_icon":1},{"id":"2518208615","title":"Geneva-based SGS Certifies Samsung Electronics' QD TV Sheet as Cadmium-Free","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208615","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518208615?lang=en_us&edition=fundamental","pubTime":"2025-03-12 09:55","pubTimestamp":1741744500,"startTime":"0","endTime":"0","summary":"Geneva-based certification body SGS certified Samsung Electronics'  quantum dot  sheet used in QD TVs as cadmium-free and said it complied with the EU's restriction of hazardous substances directive.SGS verified that Samsung's QD film meets stringent safety and environmental standards, Samsung Electronics said in a Wednesday release.Shares of the company rose nearly 2% in recent trade on Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4563","TV","BK4503","BK4166","QD","BK4100"],"gpt_icon":0},{"id":"2518244572","title":"Mineralys Therapeutics Announces Positive Topline Results from Launch-HTN and Advance-HTN Pivotal Trials of Lorundrostat for the Treatment of Uncontrolled or Resistant Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2518244572","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518244572?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:00","pubTimestamp":1741604400,"startTime":"0","endTime":"0","summary":"– Launch-HTN met its primary endpoint with lorundrostat 50 mg dose achieving a 16.9 mmHg reduction in systolic blood pressure, and a 9.1 mmHg placebo-adjusted reduction (p-value < 0.0001) assessed by ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/10/3039559/0/en/Mineralys-Therapeutics-Announces-Positive-Topline-Results-from-Launch-HTN-and-Advance-HTN-Pivotal-Trials-of-Lorundrostat-for-the-Treatment-of-Uncontrolled-or-Resistant-Hypertension.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","BK4503","BK4139","BK4563","ARB","QD","LENZ"],"gpt_icon":0},{"id":"2514221683","title":"Blueprint Medicines Highlights Leading Portfolio of Mast Cell-Targeted Therapies at 2025 AAAAI / WAO Joint Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514221683","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514221683?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"-- Updated data show AYVAKIT  was safe and effective for long-term treatment of ISM, with sustained symptom and quality-of-life benefit and no new safety signals with multiple years of therapy --. -- AYVAKIT-treated patients achieved improvements in bone health based on an analysis of bone mineral density scans, underscoring the importance of treating patients early in the ISM disease course --. -- BLU-808 healthy volunteer trial results demonstrate wide therapeutic window for modulating mast cell activity, affirming potential as best- and first-in-class oral wild-type KIT inhibitor --. AYVAKIT: PIONEER Three-Year Efficacy and Safety Data in ISM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/blueprint-medicines-highlights-leading-portfolio-130000418.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blueprint-medicines-highlights-leading-portfolio-130000418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4505","BK4563","BK4139","JYNT","LU0053671581.USD","QD","BK4185","BK4218","BK4188","ASM","BK4166","BPMC","SM","BK4181","PK","BK4503"],"gpt_icon":0},{"id":"2514867732","title":"Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867732","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514867732?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:02","pubTimestamp":1740603720,"startTime":"0","endTime":"0","summary":"Company anticipates substantially completing enrollment this year in ongoing Phase 3 RASolute 302 trial of daraxonrasib in previously treated metastatic pancreatic cancer to enable expected data readout in 2026. Company is activating study sites for Phase 3 RASolve 301 trial of daraxonrasib in previously treated locally advanced or metastatic RAS mutant non-small cell lung cancer. Company anticipates initiating two additional registrational trials of daraxonrasib in earlier lines of treatment for pancreatic cancer in the second half of 2025. Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time. REDWOOD CITY, Calif., Feb. 26, 2025  -- Revolution Medicines, Inc. , a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter and full year ended December 31, 2024, and provided an update on corporate progress.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/revolution-medicines-reports-fourth-quarter-210200565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4196","LU0124384867.USD","LU1720051108.HKD","RVMD","LU1854103824.USD","LU1720051017.SGD","BK4585","IE00B7SZLL34.SGD","BK4139","IE00BZ199S13.USD","LU0058720904.USD","BK4166","LU1059921491.USD","LU0868494617.USD","BK4211","LU0724618433.USD","LU1861214812.USD","MDCO","IE00BD6J9T35.USD","LU1861215975.USD","LU2357305700.SGD","CI","LU1861220033.SGD","LU2065732104.USD","BK4092","LU1861219969.SGD","LU2298322129.HKD","ON","PRGS","QD","RVMDW","BK4605","LU0289739699.SGD","LU1548497426.USD","LU1978683503.SGD","LU0348723411.USD","BK4195","BK4512","PFS","LU1854104046.USD","BK4563","NE","BK4503","IE00B19Z3B42.SGD","BK4097","IE0002270589.USD","IE00B19Z3581.USD","BK4588","LU2360107325.USD","OS"],"gpt_icon":0},{"id":"2512111049","title":"February 2025's Top US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111049","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512111049?lang=en_us&edition=fundamental","pubTime":"2025-02-19 08:11","pubTimestamp":1739923865,"startTime":"0","endTime":"0","summary":"As of February 2025, the U.S. stock market is experiencing a notable upswing, with the S&P 500 reaching record highs and major indices showing positive momentum. In this context, penny stocks—often seen as investments in smaller or newer companies—remain a relevant area for potential growth opportunities. While the term \"penny stocks\" might seem outdated, these investments can still offer significant returns when backed by strong financial health and strategic positioning. Let's explore several penny stocks that could pair balance sheet strength with long-term potential.Overview: Dingdong  Limited is an e-commerce company operating in China, with a market capitalization of approximately $754.10 million.Take a closer look at Dingdong 's potential here in our financial health report.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/february-2025s-top-us-penny-001105463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BABB","BK4503","DDL","BK4539","QD","BK4233","BK4209","SB","BK4080","PHX","BK4205","SRG","BK4213","BK4021","BK4563","REIT","PVL","BK4166","BK4113"],"gpt_icon":0},{"id":"2512159344","title":"Arcus Biosciences Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor, and Announces Pricing of $150 Million Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2512159344","media":"Business Wire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512159344?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:57","pubTimestamp":1739879820,"startTime":"0","endTime":"0","summary":"Gilead Sciences’ window to exercise its option to casdatifan has expired; $150 million financing enables Arcus to independently advance its development program for casdatifan. New data from the ARC-20 study in patients with clear cell renal cell carcinoma  showed that casdatifan monotherapy demonstrated improvements in the rate of primary progression, overall response rate  and progression-free survival  and reinforced its differentiation relative to published data from studies with HIF-2a inhibitors to date. Arcus will host a conference call today to discuss the ARC-20 results and casdatifan development plans at 5:00 AM PT / 8:00 AM ET. The new data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in ccRCC, were presented in a rapid oral session at the 2025 American Society of Clinical Oncology  Genitourinary  Cancers Symposium by Dr. Toni Choueiri, Dana-Farber Cancer Institute. The presentation included ORR for the 50mg twice-daily  cohort, 50mg o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcus-biosciences-retains-rights-casdatifan-115700300.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","PFS","BK4211","BK4563","RCUS","ORR","QD","BK4139","BK4179","IO","BK4166","BK4195"],"gpt_icon":0},{"id":"2511860458","title":"New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2511860458","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511860458?lang=en_us&edition=fundamental","pubTime":"2025-02-16 04:45","pubTimestamp":1739652300,"startTime":"0","endTime":"0","summary":"A 9.7-month median progression-free survival  was reached for the 50mg twice-daily  casdatifan monotherapy cohort of the Phase 1/1b ARC-20 study; mPFS was not yet reached for other cohorts. Across all three monotherapy cohorts presented, casdatifan demonstrated improvements in the rate of primary progression, overall response rate  and progression-free survival  relative to published data from studies with HIF-2a inhibitors to date. Arcus will host a conference call to discuss these data at 5:00 AM PT / 8:00 AM ET on Tuesday, February 18, 2025. \"The newest data are from the 100mg cohort using the tablet formulation and the expected go-forward dose for pivotal studies, which showed a 33% confirmed response rate despite the relatively short follow-up,\" said Richard Markus, M.D., Ph.D., chief medical officer at Arcus Biosciences. \"Casdatifan continues to be well tolerated, with a very low discontinuation rate, supporting its strong potential in combination therapy. We look forward to shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/data-demonstrated-best-class-potential-204500902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4563","BK4211","BK4179","QD","BK4503","ORR","PFS","RCUS","BK4139","BK4195","IO","BK4166"],"gpt_icon":0},{"id":"2511518079","title":"QD Laser, Inc. Reports Mixed Financial Results Amid Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2511518079","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511518079?lang=en_us&edition=fundamental","pubTime":"2025-02-13 16:20","pubTimestamp":1739434817,"startTime":"0","endTime":"0","summary":"QD Laser, Inc. ( ($JP:6613) ) has shared an update. QD Laser, Inc. reported its financial results for the nine months ending December 31, 2024, sho...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-mixed-financial-results-amid-sales-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qd-laser-inc-reports-mixed-financial-results-amid-sales-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QD"],"gpt_icon":0},{"id":"2511934597","title":"QD Laser 9-Mos Parent Loss Y328.00M Vs Loss Y369.00M","url":"https://stock-news.laohu8.com/highlight/detail?id=2511934597","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511934597?lang=en_us&edition=fundamental","pubTime":"2025-02-13 15:30","pubTimestamp":1739431800,"startTime":"0","endTime":"0","summary":"QD Laser Inc.  Japan Nine Months Ended December 31 PARENT20242023 RevenueY925.00 mlnY904.00 mln Operating Profit Pretax Profit Net Profit Per share Earnings Dividend First quarterN/AN/A MidyearY0.00Y0.00 Third quarterN/AN/A Year-endY0.00Y0.00 AnnualY0.00Y0.00 Figures in parentheses are losses. Results are based on Japanese accounting standards. Dividends for periods in the future are forecasts.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","BK4166","QD","BK4563"],"gpt_icon":0},{"id":"2510800545","title":"Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2510800545","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510800545?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:00","pubTimestamp":1739275200,"startTime":"0","endTime":"0","summary":"THB335 Phase 1 data support advancement into Phase 2 clinical trial inchronic spontaneous urticaria (CSU) Company initiating process to leverage balance sheet strength tomaximize shareholder value  Ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3024041/0/en/Third-Harmonic-Bio-Announces-Phase-1-Clinical-Results-for-THB335-and-Provides-Corporate-Strategic-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4020","BK4563","QD","BK4166","HLIT","BK4503"],"gpt_icon":0},{"id":"2510815670","title":"Arcus Biosciences to Present New Data from Casdatifan, a HIF-2a Inhibitor, in an Oral Presentation at the 2025 ASCO GU Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2510815670","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510815670?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:00","pubTimestamp":1739224800,"startTime":"0","endTime":"0","summary":"New data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in clear cell renal cell carcinoma , will be presented in a rapid oral session by Dr. Toni Choueiri, Dana-Farber Cancer Institute. The presentation will include initial data from the 100mg once-daily  tablet cohort and updated data for the 50mg twice-daily  and 50mg QD cohorts. Arcus will host a conference call to discuss the ARC-20 data at 5:00 AM PT / 8:00 AM ET on Tuesday, February 18, 2025. The oral presentation will highlight safety and efficacy data from three cohorts of ARC-20, which evaluated casdatifan monotherapy in patients that had received both prior TKI and anti-PD-1 therapy. The presentation will include initial data for the 100mg QD tablet cohort, our selected dose and formulation for Arcus’s Phase 3 studies, as well as updated data for the 50mg BID and 50mg QD expansion cohorts of ARC-20.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/arcus-biosciences-present-data-casdatifan-220000222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QD","BK4139","BK4166","RCUS","BK4503","BK4563"],"gpt_icon":0},{"id":"2508345850","title":"Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345850","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508345850?lang=en_us&edition=fundamental","pubTime":"2025-02-04 19:45","pubTimestamp":1738669500,"startTime":"0","endTime":"0","summary":"Full-Year 2024 Revenues of $63.6 Billion, Reflecting 7% Year-over-Year Operational Growth. Excluding Contributions from Paxlovid and Comirnaty, Revenues Grew 12% Operationally. Full-Year 2024 Reported Diluted EPS of $1.41 and Adjusted Diluted EPS of $3.11. Fourth-Quarter 2024 Revenues of $17.8 Billion, Reflecting 21% Year-over-Year Operational Growth. Fourth-Quarter 2024 Reported Diluted EPS of $0.07 and Adjusted Diluted EPS of $0.63. On Track to Deliver Overall Net Cost Savings of Approximately $4.5 Billion by End of 2025 from Ongoing Cost Realignment Program. Reaffirms All Components of Full-Year 2025 Financial Guidance, including Revenues in a Range of $61.0 to $64.0 Billion and Adjusted Diluted EPS in a Range of $2.80 to $3.00. NEW YORK, February 04, 2025----Pfizer Inc.  reported financial results for fourth-quarter and full-year 2024 and reaffirmed its 2025 financial guidance provided on December 17, 2024.The fourth-quarter 2024 earnings presentation and accompanying prepared rema","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"e75b2b7dcb07c669b5aa92e4e319edbe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-reports-strong-full-2024-114500880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","IE00B19Z3B42.SGD","LU0122379950.USD","MBC","PFS","BK4533","IE00BLSP4452.SGD","BK4195","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","LU1883839398.USD","BK4166","BK4548","BK4551","BNTX","BK4139","LU1066051498.USD","BCG","LU0306806265.USD","SG9999002232.USD","BK4135","BK4097","BK4211","BK4592","LU0225771236.USD","SGXZ57979304.SGD","IE00BLSP4239.USD","ORR","BK4599","BK4503","BK4581","BK4201","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","EC","LU1894683348.USD","OS","PFE","LU0306807586.USD","LU0321505868.SGD","SG9999002224.SGD","BK4535","QD","BK4568","LU0868494617.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"1177892181","title":"Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting","url":"https://stock-news.laohu8.com/highlight/detail?id=1177892181","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177892181?lang=en_us&edition=fundamental","pubTime":"2025-02-01 04:56","pubTimestamp":1738356986,"startTime":"0","endTime":"0","summary":"Qudian Inc. , a consumer-oriented technology company, saw its stock price plummet 5.05% in the intraday session on Friday. The decline came after the company announced the appointment of Marcum Asia CPAs LLP as its new independent registered public accounting firm.While auditor changes are not uncommon for companies, Qudian's announcement highlighted some potential concerns regarding its financial reporting and auditing processes. The company had initially appointed BDO China Shu Lun Pan Certifi","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Qudian Inc. Plummets 5.05% as Auditor Change Raises Concerns Over Financial Reporting","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["QD"],"gpt_icon":0},{"id":"2507953667","title":"Qudian Inc. Announces Appointment of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2507953667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507953667?lang=en_us&edition=fundamental","pubTime":"2025-01-31 18:17","pubTimestamp":1738318669,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUA7CVQLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","QD","BK4503","BK4166"],"gpt_icon":0},{"id":"2507953125","title":"Qudian Inc. Announces Appointment of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2507953125","media":"PR Newswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507953125?lang=en_us&edition=fundamental","pubTime":"2025-01-31 18:00","pubTimestamp":1738317600,"startTime":"0","endTime":"0","summary":"XIAMEN, China, Jan. 31, 2025 /PRNewswire/ -- Qudian Inc.  , a consumer-oriented technology company, today announced the appointment of Marcum Asia CPAs LLP  as the Company's new independent registered public accounting firm.The Company previously announced the appointment of BDO China Shu Lun Pan Certified Public Accountants LLP  as its independent registered public accounting firm on September 6, 2024. After the announcement, BDO informed the Company's management and audit committee that, due to constraints on its internal resources, BDO may not be able to complete its audit work according to the timetable proposed by the Company. After further discussions, the Company decided to revoke BDO's appointment and BDO accepted the revocation. The revocation of BDO's appointment was not as a result of any disagreement between the Company and BDO on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures.After carefully considering add","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/qudian-inc-announces-appointment-auditor-100000240.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qudian-inc-announces-appointment-auditor-100000240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4166","QD","BK4563","BK4503"],"gpt_icon":0},{"id":"2505250427","title":"3 Promising Penny Stocks On US Exchanges In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505250427","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505250427?lang=en_us&edition=fundamental","pubTime":"2025-01-21 08:06","pubTimestamp":1737417995,"startTime":"0","endTime":"0","summary":"As of January 2025, the U.S. stock market is experiencing a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting their best weekly gains in two months, driven by a rally in big-tech stocks. For investors looking beyond established giants, penny stocks—often representing smaller or newer companies—continue to hold potential despite being considered an outdated term. These stocks can offer affordability and growth potential when paired with strong financials; here we explore three penny stocks that stand out for their financial strength and resilience.GSI Technology, Inc. faces challenges typical of penny stocks, with increasing losses over the past five years and a negative return on equity. The company is unprofitable and has less than a year of cash runway, although its short-term assets exceed both short- and long-term liabilities. Despite high volatility in its share price, GSI's recent selection by the U.S. Army for an SBIR contract highlights potenti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-us-000635303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4551","BK4563","SB","BK4539","BK4113","GSIT","BK4503","BABB","DDL","BK4021","QD","BK4166","BK4209"],"gpt_icon":0},{"id":"2503546521","title":"C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2503546521","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503546521?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:00","pubTimestamp":1736856000,"startTime":"0","endTime":"0","summary":"Cemsidomide Data Presented at American Society of Hematology (ASH) Annual Meeting Support Best-in-Class Profile; Program Advancing to Next Phase of Clinical Development in Multiple Myeloma and Non-Hod","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009167/0/en/C4-Therapeutics-Announces-2025-Milestones-Across-Clinical-Portfolio-of-Degrader-Medicines-Pursuing-Targets-of-High-Unmet-Need-in-Oncology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","QD","LENZ","MDCO","ASH","CRC","BK4109","BK4503","LU0456854461.SGD","LU0266512127.USD","BK4563","BK4139","CCCC","LU2463526074.USD","BK4213"],"gpt_icon":0},{"id":"2502461865","title":"Tyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502461865","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502461865?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:00","pubTimestamp":1736514000,"startTime":"0","endTime":"0","summary":"-TYRA appoints urologic oncologist, Erik Goluboff, M.D., as SVP, Clinical Development to lead NMIBC-. -First patient expected to be dosed in SURF302 in Q2 2025-. CARLSBAD, Calif., Jan. 10, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor  biology, announced today that the U.S. Food and Drug Administration  cleared its Investigational New Drug  application for TYRA-300 allowing the company to proceed with a Phase 2 clinical trial of TYRA-300 in low-grade, intermediate risk non-muscle invasive bladder cancer . This program will be led by newly appointed Dr. Erik Goluboff, SVP, Clinical Development of TYRA, who brings more than thirty years of experience as an academic urologic oncologist, principal investigator, practicing urologist and most recently Principal Medical Lead for GU/GI cancers at Genentech/Roche.Dr. Goluboff joins","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/tyra-biosciences-receives-ind-clearance-130000689.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tyra-biosciences-receives-ind-clearance-130000689.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4503","PFS","BK4211","BK4563","CR","BK4161","QD","BK4153","TYRA","BK4139","ACH","BK4166","BK4195"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-20","symbol":"QD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-22","symbol":"QD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1732251600000,"reportTimeType":"pre","actualEps":0.1},{"market":"US","date":"2024-09-06","symbol":"QD","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725595200000,"reportTimeType":"pre","actualEps":0.07},{"market":"US","date":"2024-06-13","symbol":"QD","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1718251200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-03-18","symbol":"QD","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710734400000,"reportTimeType":"pre","actualEps":-0.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QD","date":"2025-04-30","current":35.734802,"percent":0.866071,"low":-88.607914,"twenty":-4.50361,"median":2.083522,"eighty":16.552549,"high":110.235059,"avg":11.290698,"sd":34.631295,"marketCap":450795323},"quantilePoints":[{"date":"2020-05-01","current":0.878138,"twenty":2.284286,"median":4.944031,"eighty":9.808673,"marketCap":405950457},{"date":"2020-05-08","current":0.962192,"twenty":2.215217,"median":4.934765,"eighty":9.770965,"marketCap":444008313},{"date":"2020-05-15","current":0.910759,"twenty":2.195189,"median":4.927236,"eighty":9.748922,"marketCap":418636409},{"date":"2020-05-22","current":0.831163,"twenty":2.178041,"median":4.907052,"eighty":9.736972,"marketCap":380578554},{"date":"2020-05-29","current":1.485647,"twenty":2.15827,"median":4.857685,"eighty":9.731582,"marketCap":380578554},{"date":"2020-06-05","current":1.513828,"twenty":2.111924,"median":4.836038,"eighty":9.713673,"marketCap":390727315},{"date":"2020-06-12","current":1.494313,"twenty":2.077217,"median":4.820821,"eighty":9.690916,"marketCap":385652934},{"date":"2020-06-19","current":1.697674,"twenty":2.054702,"median":4.802938,"eighty":9.676676,"marketCap":438933932},{"date":"2020-06-26","current":1.709075,"twenty":1.997591,"median":4.760441,"eighty":9.653813,"marketCap":441471122},{"date":"2020-07-02","current":1.68657,"twenty":1.963896,"median":4.75815,"eighty":9.642907,"marketCap":436396741},{"date":"2020-07-10","current":2.312239,"twenty":1.963896,"median":4.748623,"eighty":9.604742,"marketCap":603851305},{"date":"2020-07-17","current":1.97954,"twenty":1.963896,"median":4.718462,"eighty":9.559259,"marketCap":517586833},{"date":"2020-07-24","current":1.616747,"twenty":1.918817,"median":4.713887,"eighty":9.538168,"marketCap":421173599},{"date":"2020-07-31","current":1.568191,"twenty":1.76894,"median":4.700634,"eighty":9.522584,"marketCap":411024838},{"date":"2020-08-07","current":1.614876,"twenty":1.736998,"median":4.673639,"eighty":9.493529,"marketCap":423710790},{"date":"2020-08-14","current":1.755578,"twenty":1.705998,"median":4.644245,"eighty":9.483072,"marketCap":461768645},{"date":"2020-08-21","current":1.622789,"twenty":1.673427,"median":4.641146,"eighty":9.471666,"marketCap":428785170},{"date":"2020-08-28","current":1.591166,"twenty":1.651695,"median":4.639855,"eighty":9.458685,"marketCap":423710790},{"date":"2020-09-04","current":1.471861,"twenty":1.642989,"median":4.637355,"eighty":9.446127,"marketCap":393264505},{"date":"2020-09-11","current":2.9708,"twenty":1.644704,"median":4.630228,"eighty":9.441013,"marketCap":375519436},{"date":"2020-09-18","current":2.763282,"twenty":1.645206,"median":4.617694,"eighty":9.438537,"marketCap":352683795},{"date":"2020-09-25","current":2.544944,"twenty":1.64953,"median":4.600475,"eighty":9.427936,"marketCap":322236273},{"date":"2020-10-02","current":2.612554,"twenty":1.651477,"median":4.596099,"eighty":9.420407,"marketCap":332385447},{"date":"2020-10-09","current":2.75249,"twenty":1.651881,"median":4.578229,"eighty":9.392619,"marketCap":355221088},{"date":"2020-10-16","current":2.537281,"twenty":1.658807,"median":4.56539,"eighty":9.362569,"marketCap":327310860},{"date":"2020-10-23","current":3.004667,"twenty":1.665444,"median":4.549138,"eighty":9.317241,"marketCap":388205903},{"date":"2020-10-30","current":2.632757,"twenty":1.672076,"median":4.545601,"eighty":9.282307,"marketCap":339997327},{"date":"2020-11-06","current":2.718404,"twenty":1.683941,"median":4.537883,"eighty":9.247967,"marketCap":355221088},{"date":"2020-11-13","current":3.007111,"twenty":1.690294,"median":4.530427,"eighty":9.222351,"marketCap":393280490},{"date":"2020-11-20","current":2.891564,"twenty":1.696384,"median":4.514509,"eighty":9.207035,"marketCap":380594023},{"date":"2020-11-27","current":2.781782,"twenty":1.702668,"median":4.503584,"eighty":9.203814,"marketCap":365370262},{"date":"2020-12-04","current":2.64678,"twenty":1.707844,"median":4.491432,"eighty":9.193684,"marketCap":350146501},{"date":"2020-12-11","current":2.557096,"twenty":1.724561,"median":4.482553,"eighty":9.147292,"marketCap":337460034},{"date":"2020-12-18","current":5.102651,"twenty":1.736153,"median":4.48545,"eighty":9.115708,"marketCap":322236273},{"date":"2020-12-24","current":4.937025,"twenty":1.737666,"median":4.491432,"eighty":9.10861,"marketCap":312087099},{"date":"2020-12-31","current":5.537487,"twenty":1.740124,"median":4.502956,"eighty":9.092785,"marketCap":350146501},{"date":"2021-01-08","current":6.444668,"twenty":1.747874,"median":4.514509,"eighty":9.047388,"marketCap":411041545},{"date":"2021-01-15","current":7.208537,"twenty":1.758064,"median":4.530427,"eighty":9.019783,"marketCap":459250121},{"date":"2021-01-22","current":8.445492,"twenty":1.768009,"median":4.537043,"eighty":8.984768,"marketCap":537906219},{"date":"2021-01-29","current":7.942919,"twenty":1.76894,"median":4.542259,"eighty":8.938442,"marketCap":509995991},{"date":"2021-02-05","current":11.924246,"twenty":1.851142,"median":4.548275,"eighty":9.028537,"marketCap":761188047},{"date":"2021-02-12","current":14.445936,"twenty":1.868824,"median":4.559967,"eighty":9.120701,"marketCap":923574830},{"date":"2021-02-19","current":12.380316,"twenty":1.88933,"median":4.571167,"eighty":9.207035,"marketCap":791635568},{"date":"2021-02-26","current":8.51412,"twenty":1.913945,"median":4.592159,"eighty":9.247967,"marketCap":542980806},{"date":"2021-03-05","current":8.703275,"twenty":1.943752,"median":4.599299,"eighty":9.317241,"marketCap":553129980},{"date":"2021-03-12","current":10.400664,"twenty":1.953215,"median":4.601433,"eighty":9.361164,"marketCap":659696307},{"date":"2021-03-19","current":11.042064,"twenty":1.961921,"median":4.622901,"eighty":9.424224,"marketCap":700293003},{"date":"2021-03-26","current":9.04649,"twenty":1.96442,"median":4.63729,"eighty":9.438537,"marketCap":570891035},{"date":"2021-04-01","current":3.967248,"twenty":1.973018,"median":4.623968,"eighty":9.430511,"marketCap":579381903},{"date":"2021-04-09","current":3.769324,"twenty":1.979189,"median":4.609564,"eighty":9.424508,"marketCap":551551331},{"date":"2021-04-16","current":3.234782,"twenty":1.981324,"median":4.600302,"eighty":9.421077,"marketCap":475649772},{"date":"2021-04-23","current":3.274103,"twenty":1.983504,"median":4.594129,"eighty":9.399256,"marketCap":483239928},{"date":"2021-04-30","current":3.503774,"twenty":1.992131,"median":4.576016,"eighty":9.381766,"marketCap":518830805},{"date":"2021-05-07","current":3.345251,"twenty":1.997888,"median":4.559967,"eighty":9.365612,"marketCap":498583750},{"date":"2021-05-14","current":3.211397,"twenty":2.013914,"median":4.548275,"eighty":9.32711,"marketCap":478336694},{"date":"2021-05-21","current":3.515608,"twenty":2.035612,"median":4.542259,"eighty":9.288573,"marketCap":523892569},{"date":"2021-05-28","current":3.479656,"twenty":2.049113,"median":4.537043,"eighty":9.254986,"marketCap":523892569},{"date":"2021-06-04","current":3.679868,"twenty":2.056273,"median":4.530427,"eighty":9.23165,"marketCap":551732271},{"date":"2021-06-11","current":3.563713,"twenty":2.061219,"median":4.514509,"eighty":9.212368,"marketCap":534016097},{"date":"2021-06-18","current":2.275344,"twenty":2.061219,"median":4.502956,"eighty":9.203999,"marketCap":678276370},{"date":"2021-06-25","current":2.191357,"twenty":2.056273,"median":4.491079,"eighty":9.196938,"marketCap":652967550},{"date":"2021-07-02","current":1.87323,"twenty":2.046808,"median":4.479655,"eighty":9.160587,"marketCap":556794035},{"date":"2021-07-09","current":1.730432,"twenty":2.024506,"median":4.46865,"eighty":9.119037,"marketCap":513769041},{"date":"2021-07-16","current":1.662239,"twenty":1.98682,"median":4.463577,"eighty":9.110495,"marketCap":493521986},{"date":"2021-07-23","current":1.586083,"twenty":1.97535,"median":4.450513,"eighty":9.101009,"marketCap":470744048},{"date":"2021-07-30","current":1.53875,"twenty":1.950793,"median":4.445107,"eighty":9.084999,"marketCap":458089638},{"date":"2021-08-06","current":1.552306,"twenty":1.869705,"median":4.442504,"eighty":9.050979,"marketCap":460620520},{"date":"2021-08-13","current":1.363504,"twenty":1.777939,"median":4.417738,"eighty":9.042899,"marketCap":404941116},{"date":"2021-08-20","current":1.283065,"twenty":1.747325,"median":4.38053,"eighty":9.023933,"marketCap":379632297},{"date":"2021-08-27","current":1.300955,"twenty":1.735308,"median":4.371685,"eighty":9.001366,"marketCap":404941116},{"date":"2021-09-03","current":1.403066,"twenty":1.725747,"median":4.364162,"eighty":8.979599,"marketCap":437842582},{"date":"2021-09-10","current":1.335883,"twenty":1.705998,"median":4.3515,"eighty":8.958924,"marketCap":417595526},{"date":"2021-09-17","current":1.340381,"twenty":1.689297,"median":4.343939,"eighty":8.938442,"marketCap":417595526},{"date":"2021-09-24","current":1.23478,"twenty":1.666673,"median":4.335386,"eighty":8.908672,"marketCap":384694060},{"date":"2021-10-01","current":1.206741,"twenty":1.651695,"median":4.321627,"eighty":8.904129,"marketCap":377101415},{"date":"2021-10-08","current":1.319613,"twenty":1.642989,"median":4.309588,"eighty":8.904051,"marketCap":412533762},{"date":"2021-10-15","current":1.261176,"twenty":1.63643,"median":4.279097,"eighty":8.895162,"marketCap":394817588},{"date":"2021-10-22","current":1.475957,"twenty":1.622789,"median":4.248476,"eighty":8.878523,"marketCap":465682284},{"date":"2021-10-29","current":1.343957,"twenty":1.612811,"median":4.241881,"eighty":8.8482,"marketCap":422657290},{"date":"2021-11-05","current":1.334535,"twenty":1.602824,"median":4.216939,"eighty":8.777134,"marketCap":420126408},{"date":"2021-11-12","current":1.386525,"twenty":1.586083,"median":4.210169,"eighty":8.758487,"marketCap":437842582},{"date":"2021-11-19","current":1.219827,"twenty":1.571444,"median":4.181522,"eighty":8.71027,"marketCap":384694060},{"date":"2021-11-26","current":1.172466,"twenty":1.565489,"median":4.172071,"eighty":8.704674,"marketCap":369508769},{"date":"2021-12-03","current":0.993357,"twenty":1.547798,"median":4.150379,"eighty":8.670525,"marketCap":313829365},{"date":"2021-12-10","current":1.12025,"twenty":1.526625,"median":4.120261,"eighty":8.649487,"marketCap":354323477},{"date":"2021-12-17","current":1.090651,"twenty":1.513291,"median":4.096041,"eighty":8.570458,"marketCap":227171966},{"date":"2021-12-23","current":1.226168,"twenty":1.507688,"median":4.064994,"eighty":8.551028,"marketCap":255619079},{"date":"2021-12-31","current":1.173249,"twenty":1.493501,"median":4.041014,"eighty":8.545412,"marketCap":245267772},{"date":"2022-01-07","current":1.23969,"twenty":1.483167,"median":4.018638,"eighty":8.539701,"marketCap":258149961},{"date":"2022-01-14","current":1.283356,"twenty":1.472808,"median":3.996998,"eighty":8.523772,"marketCap":268273489},{"date":"2022-01-21","current":1.141622,"twenty":1.457851,"median":3.988936,"eighty":8.508926,"marketCap":239168347},{"date":"2022-01-28","current":1.053331,"twenty":1.44714,"median":3.979444,"eighty":8.488011,"marketCap":219908335},{"date":"2022-02-04","current":1.162555,"twenty":1.426053,"median":3.967188,"eighty":8.464405,"marketCap":242711581},{"date":"2022-02-11","current":1.199378,"twenty":1.413906,"median":3.942635,"eighty":8.453313,"marketCap":250607933},{"date":"2022-02-18","current":1.097087,"twenty":1.39743,"median":3.939304,"eighty":8.437152,"marketCap":230310260},{"date":"2022-02-25","current":1.008908,"twenty":1.387125,"median":3.918967,"eighty":8.420457,"marketCap":212087909},{"date":"2022-03-04","current":0.908009,"twenty":1.367808,"median":3.907082,"eighty":8.399056,"marketCap":190828501},{"date":"2022-03-11","current":0.869861,"twenty":1.363727,"median":3.88232,"eighty":8.372883,"marketCap":182223502},{"date":"2022-03-18","current":2.787669,"twenty":1.357838,"median":3.876736,"eighty":8.339036,"marketCap":258149961},{"date":"2022-03-25","current":3.336423,"twenty":1.35913,"median":3.866977,"eighty":8.316599,"marketCap":308767601},{"date":"2022-04-01","current":3.389728,"twenty":1.362482,"median":3.852155,"eighty":8.28079,"marketCap":313829365},{"date":"2022-04-08","current":3.444999,"twenty":1.363727,"median":3.83615,"eighty":8.259061,"marketCap":318891129},{"date":"2022-04-14","current":3.013824,"twenty":1.364618,"median":3.815106,"eighty":8.239513,"marketCap":278397017},{"date":"2022-04-22","current":2.765355,"twenty":1.365216,"median":3.792152,"eighty":8.223331,"marketCap":250557316},{"date":"2022-04-29","current":3.058969,"twenty":1.365918,"median":3.769324,"eighty":8.171844,"marketCap":272672787},{"date":"2022-05-06","current":2.828864,"twenty":1.366925,"median":3.715418,"eighty":8.148875,"marketCap":249975302},{"date":"2022-05-13","current":2.211076,"twenty":1.371339,"median":3.703028,"eighty":8.125714,"marketCap":191880850},{"date":"2022-05-20","current":2.2673,"twenty":1.379889,"median":3.673757,"eighty":8.037983,"marketCap":199556084},{"date":"2022-05-27","current":2.096332,"twenty":1.382511,"median":3.648946,"eighty":8.030691,"marketCap":184331853},{"date":"2022-06-03","current":2.359877,"twenty":1.385722,"median":3.622937,"eighty":7.960473,"marketCap":208720919},{"date":"2022-06-10","current":2.330771,"twenty":1.388925,"median":3.617264,"eighty":7.939299,"marketCap":204656075},{"date":"2022-06-17","current":-53.377821,"twenty":1.370456,"median":3.60663,"eighty":7.827996,"marketCap":254999551},{"date":"2022-06-24","current":-57.897972,"twenty":1.364977,"median":3.600751,"eighty":7.800209,"marketCap":277722283},{"date":"2022-07-01","current":-65.908222,"twenty":1.358097,"median":3.577552,"eighty":7.791874,"marketCap":315593503},{"date":"2022-07-08","current":-61.093466,"twenty":1.356202,"median":3.560157,"eighty":7.775858,"marketCap":292870771},{"date":"2022-07-15","current":-63.27086,"twenty":1.346881,"median":3.54788,"eighty":7.722016,"marketCap":300445015},{"date":"2022-07-22","current":-61.624682,"twenty":1.339656,"median":3.542243,"eighty":7.650027,"marketCap":292870771},{"date":"2022-07-29","current":-59.967811,"twenty":1.335074,"median":3.524398,"eighty":7.62701,"marketCap":285296527},{"date":"2022-08-05","current":-59.057527,"twenty":1.329074,"median":3.509691,"eighty":7.610735,"marketCap":280247031},{"date":"2022-08-12","current":-57.299923,"twenty":1.30399,"median":3.480521,"eighty":7.56646,"marketCap":272672787},{"date":"2022-08-19","current":-57.399968,"twenty":1.294829,"median":3.474363,"eighty":7.529188,"marketCap":270148039},{"date":"2022-08-26","current":-55.693437,"twenty":1.28847,"median":3.451858,"eighty":7.459046,"marketCap":260049047},{"date":"2022-09-02","current":-50.865077,"twenty":1.282236,"median":3.439352,"eighty":7.329916,"marketCap":236543642},{"date":"2022-09-09","current":-4.427371,"twenty":1.27284,"median":3.41825,"eighty":7.262178,"marketCap":232276818},{"date":"2022-09-16","current":-4.711862,"twenty":1.26766,"median":3.389728,"eighty":7.055763,"marketCap":244900558},{"date":"2022-09-23","current":-4.507036,"twenty":1.255102,"median":3.334228,"eighty":6.430231,"marketCap":229752070},{"date":"2022-09-30","current":-4.449063,"twenty":1.241844,"median":3.305952,"eighty":6.36321,"marketCap":227227322},{"date":"2022-10-07","current":-4.649044,"twenty":1.233685,"median":3.272439,"eighty":6.315153,"marketCap":237427304},{"date":"2022-10-14","current":-4.397095,"twenty":1.224175,"median":3.258319,"eighty":6.268831,"marketCap":222177826},{"date":"2022-10-21","current":-4.517358,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226697125},{"date":"2022-10-28","current":-4.17876,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":209352106},{"date":"2022-11-04","current":-4.316899,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":218365457},{"date":"2022-11-11","current":-4.435179,"twenty":1.21703,"median":3.258055,"eighty":6.263868,"marketCap":226747620},{"date":"2022-11-18","current":-4.188263,"twenty":1.206309,"median":3.214152,"eighty":6.038554,"marketCap":213745168},{"date":"2022-11-25","current":-1.441004,"twenty":1.196321,"median":3.183506,"eighty":5.919731,"marketCap":184306606},{"date":"2022-12-02","current":-1.739144,"twenty":1.190341,"median":3.139792,"eighty":5.695609,"marketCap":227227322},{"date":"2022-12-09","current":-1.627951,"twenty":1.184355,"median":3.058969,"eighty":5.613624,"marketCap":214628830},{"date":"2022-12-16","current":-1.787897,"twenty":1.173368,"median":3.004667,"eighty":5.573461,"marketCap":235205526},{"date":"2022-12-23","current":-1.845396,"twenty":1.166568,"median":2.973405,"eighty":5.526558,"marketCap":242224325},{"date":"2022-12-30","current":-1.809474,"twenty":1.152461,"median":2.926816,"eighty":5.501262,"marketCap":240608487},{"date":"2023-01-06","current":-2.145642,"twenty":1.147922,"median":2.899588,"eighty":5.479696,"marketCap":287821275},{"date":"2023-01-13","current":-2.06881,"twenty":1.140337,"median":2.875567,"eighty":5.427519,"marketCap":282771779},{"date":"2023-01-20","current":-2.016512,"twenty":1.137891,"median":2.86131,"eighty":5.392337,"marketCap":272672787},{"date":"2023-01-27","current":-2.259537,"twenty":1.116984,"median":2.824171,"eighty":5.370803,"marketCap":305494511},{"date":"2023-02-03","current":-2.34562,"twenty":1.101853,"median":2.781782,"eighty":5.34608,"marketCap":318118251},{"date":"2023-02-10","current":-2.473528,"twenty":1.090277,"median":2.763282,"eighty":5.316369,"marketCap":333266739},{"date":"2023-02-17","current":-2.533318,"twenty":1.079518,"median":2.732178,"eighty":5.287677,"marketCap":338316236},{"date":"2023-02-24","current":-5.725247,"twenty":1.056339,"median":2.690651,"eighty":5.254644,"marketCap":297920267},{"date":"2023-03-03","current":-5.828855,"twenty":1.037848,"median":2.654874,"eighty":5.22864,"marketCap":305494511},{"date":"2023-03-10","current":-5.456639,"twenty":1.023348,"median":2.647052,"eighty":5.204033,"marketCap":285296527},{"date":"2023-03-17","current":-5.667715,"twenty":1.001884,"median":2.632757,"eighty":5.155718,"marketCap":297920267},{"date":"2023-03-24","current":-5.748207,"twenty":0.988622,"median":2.592496,"eighty":5.123544,"marketCap":302969763},{"date":"2023-03-31","current":-5.74963,"twenty":0.981636,"median":2.560383,"eighty":5.106116,"marketCap":302969763},{"date":"2023-04-06","current":-5.611278,"twenty":0.961891,"median":2.541113,"eighty":5.097377,"marketCap":295395519},{"date":"2023-04-14","current":-5.65364,"twenty":0.948412,"median":2.488418,"eighty":5.048439,"marketCap":297920267},{"date":"2023-04-21","current":-6.231763,"twenty":0.935717,"median":2.439054,"eighty":5.022245,"marketCap":328217243},{"date":"2023-04-28","current":-5.892181,"twenty":0.913999,"median":2.35477,"eighty":4.997161,"marketCap":308019259},{"date":"2023-05-05","current":-5.53935,"twenty":0.906432,"median":2.330771,"eighty":4.985267,"marketCap":290119614},{"date":"2023-05-12","current":-5.396481,"twenty":0.890665,"median":2.309302,"eighty":4.971094,"marketCap":281123657},{"date":"2023-05-19","current":-5.468089,"twenty":0.873834,"median":2.26799,"eighty":4.953015,"marketCap":281123657},{"date":"2023-05-26","current":-5.890594,"twenty":0.84026,"median":2.223866,"eighty":4.941783,"marketCap":301364560},{"date":"2023-06-02","current":-6.08478,"twenty":0.822461,"median":2.20614,"eighty":4.930121,"marketCap":310360517},{"date":"2023-06-09","current":-7.997073,"twenty":0.753762,"median":2.191357,"eighty":4.862414,"marketCap":407067056},{"date":"2023-06-16","current":14.961744,"twenty":0.730045,"median":2.189117,"eighty":4.854051,"marketCap":409316045},{"date":"2023-06-23","current":16.549358,"twenty":0.725764,"median":2.188964,"eighty":4.847095,"marketCap":449797852},{"date":"2023-06-30","current":16.548854,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":445299873},{"date":"2023-07-07","current":16.798434,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-07-14","current":18.049358,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":492528647},{"date":"2023-07-21","current":17.617452,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-07-28","current":18.520305,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":503773594},{"date":"2023-08-04","current":19.822164,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":539757422},{"date":"2023-08-11","current":20.546635,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":555500347},{"date":"2023-08-18","current":18.151135,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":485781680},{"date":"2023-08-25","current":19.54183,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":524014497},{"date":"2023-09-01","current":21.080767,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":566745293},{"date":"2023-09-08","current":17.988448,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":440801894},{"date":"2023-09-15","current":18.317701,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":452046841},{"date":"2023-09-22","current":18.211445,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":447548862},{"date":"2023-09-29","current":19.475841,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":479034712},{"date":"2023-10-06","current":18.743843,"twenty":0.721483,"median":2.188811,"eighty":4.838592,"marketCap":461042798},{"date":"2023-10-13","current":18.65139,"twenty":0.721483,"median":2.188811,"eighty":4.867143,"marketCap":458793809},{"date":"2023-10-20","current":17.497268,"twenty":0.721483,"median":2.188811,"eighty":4.934175,"marketCap":429556948},{"date":"2023-10-27","current":16.217847,"twenty":-0.124554,"median":2.185731,"eighty":4.941783,"marketCap":398071099},{"date":"2023-11-03","current":15.850472,"twenty":-0.124554,"median":2.185731,"eighty":4.959403,"marketCap":389075141},{"date":"2023-11-10","current":15.688202,"twenty":-0.124554,"median":2.185731,"eighty":4.984734,"marketCap":386826152},{"date":"2023-11-17","current":15.779975,"twenty":-0.124554,"median":2.185731,"eighty":5.009021,"marketCap":391324131},{"date":"2023-11-24","current":14.407243,"twenty":-0.124554,"median":2.185731,"eighty":5.031648,"marketCap":362087270},{"date":"2023-12-01","current":14.119989,"twenty":-0.124554,"median":2.185731,"eighty":5.061029,"marketCap":355340303},{"date":"2023-12-08","current":16.375706,"twenty":0.296324,"median":2.187935,"eighty":5.102649,"marketCap":411565034},{"date":"2023-12-15","current":5.13977,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":467789766},{"date":"2023-12-22","current":5.193137,"twenty":0.296324,"median":2.187935,"eighty":5.09701,"marketCap":470038755},{"date":"2023-12-29","current":5.167392,"twenty":-0.124554,"median":2.185731,"eighty":5.105888,"marketCap":470038755},{"date":"2024-01-05","current":5.271514,"twenty":-0.545433,"median":2.183526,"eighty":5.117907,"marketCap":476785723},{"date":"2024-01-12","current":5.442904,"twenty":-0.545433,"median":2.183526,"eighty":5.148286,"marketCap":492528647},{"date":"2024-01-19","current":5.433825,"twenty":-0.966311,"median":2.182901,"eighty":5.16623,"marketCap":488030669},{"date":"2024-01-26","current":5.069182,"twenty":-0.545433,"median":2.183526,"eighty":5.152858,"marketCap":458793809},{"date":"2024-02-02","current":5.346932,"twenty":-0.545433,"median":2.183526,"eighty":5.165068,"marketCap":481283701},{"date":"2024-02-09","current":5.478707,"twenty":-0.545433,"median":2.183526,"eighty":5.198595,"marketCap":494777637},{"date":"2024-02-16","current":6.309669,"twenty":-0.545433,"median":2.183526,"eighty":5.238229,"marketCap":568994282},{"date":"2024-02-23","current":6.132491,"twenty":-0.545433,"median":2.183526,"eighty":5.278851,"marketCap":551002368},{"date":"2024-03-01","current":6.129507,"twenty":-0.124554,"median":2.185731,"eighty":5.28407,"marketCap":551002368},{"date":"2024-03-08","current":5.831557,"twenty":-0.124554,"median":2.185731,"eighty":5.293518,"marketCap":524014497},{"date":"2024-03-15","current":6.107883,"twenty":-0.124554,"median":2.185731,"eighty":5.315877,"marketCap":548753379},{"date":"2024-03-22","current":103.435233,"twenty":-0.124554,"median":2.185731,"eighty":5.348813,"marketCap":562247315},{"date":"2024-03-28","current":103.41931,"twenty":-0.124554,"median":2.185731,"eighty":5.36835,"marketCap":559998325},{"date":"2024-04-05","current":99.779196,"twenty":-0.545433,"median":2.183526,"eighty":5.384537,"marketCap":539757422},{"date":"2024-04-12","current":101.071124,"twenty":-0.545433,"median":2.183526,"eighty":5.402533,"marketCap":546504390},{"date":"2024-04-19","current":93.598599,"twenty":-0.545433,"median":2.183526,"eighty":5.433865,"marketCap":506022583},{"date":"2024-04-26","current":101.175863,"twenty":-0.124554,"median":2.185731,"eighty":5.454663,"marketCap":546504390},{"date":"2024-05-03","current":100.260037,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":542006411},{"date":"2024-05-10","current":79.679719,"twenty":-0.124554,"median":2.185731,"eighty":5.479265,"marketCap":431840780},{"date":"2024-05-17","current":68.485221,"twenty":-0.124554,"median":2.185731,"eighty":5.504513,"marketCap":371231547},{"date":"2024-05-24","current":60.287412,"twenty":-0.124554,"median":2.185731,"eighty":5.616715,"marketCap":325774623},{"date":"2024-05-31","current":59.936079,"twenty":-0.124554,"median":2.185731,"eighty":5.781947,"marketCap":323880585},{"date":"2024-06-07","current":57.857018,"twenty":-0.124554,"median":2.185731,"eighty":5.86056,"marketCap":312516354},{"date":"2024-06-14","current":-5.111058,"twenty":-1.39972,"median":2.182277,"eighty":5.972137,"marketCap":316304431},{"date":"2024-06-21","current":-5.791635,"twenty":-1.513498,"median":2.164796,"eighty":5.975765,"marketCap":357973278},{"date":"2024-06-28","current":-5.736583,"twenty":-1.56144,"median":2.157614,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-05","current":-5.737924,"twenty":-1.647893,"median":2.11897,"eighty":5.995678,"marketCap":354185201},{"date":"2024-07-12","current":-5.544422,"twenty":-1.785668,"median":2.096332,"eighty":5.995678,"marketCap":342820970},{"date":"2024-07-15","current":-5.480589,"twenty":-1.788185,"median":2.092657,"eighty":5.995678,"marketCap":339032893},{"date":"2024-08-02","current":-5.440877,"twenty":-1.799974,"median":2.061277,"eighty":6.054033,"marketCap":337138854},{"date":"2024-08-09","current":-5.117277,"twenty":-1.845396,"median":2.034008,"eighty":6.054033,"marketCap":320092508},{"date":"2024-08-16","current":-5.450277,"twenty":-1.902036,"median":1.990803,"eighty":6.054033,"marketCap":340926931},{"date":"2024-08-23","current":-5.548409,"twenty":-2.06444,"median":1.969537,"eighty":6.054033,"marketCap":348503085},{"date":"2024-08-30","current":-5.422274,"twenty":-2.132648,"median":1.906636,"eighty":6.054033,"marketCap":342820970},{"date":"2024-09-06","current":-5.507717,"twenty":-2.192208,"median":1.858821,"eighty":6.054033,"marketCap":348503085},{"date":"2024-09-13","current":-9.164942,"twenty":-2.305525,"median":1.754206,"eighty":6.054033,"marketCap":350397124},{"date":"2024-09-20","current":-9.248138,"twenty":-2.4266,"median":1.735942,"eighty":6.054033,"marketCap":356079239},{"date":"2024-09-27","current":-9.857249,"twenty":-2.554208,"median":1.725079,"eighty":6.054033,"marketCap":382595779},{"date":"2024-10-04","current":-10.767472,"twenty":-4.167739,"median":1.694449,"eighty":6.054033,"marketCap":416688472},{"date":"2024-10-11","current":-10.349658,"twenty":-4.226527,"median":1.67005,"eighty":6.054033,"marketCap":397748087},{"date":"2024-10-18","current":-10.261164,"twenty":-4.307673,"median":1.65115,"eighty":6.054033,"marketCap":392065971},{"date":"2024-10-25","current":-11.347424,"twenty":-4.342601,"median":1.641046,"eighty":6.054033,"marketCap":433734818},{"date":"2024-10-31","current":-11.642279,"twenty":-4.424771,"median":1.629603,"eighty":6.054033,"marketCap":445099049},{"date":"2024-11-08","current":-11.890684,"twenty":-4.437526,"median":1.614876,"eighty":6.064803,"marketCap":452675203},{"date":"2024-11-15","current":-11.580432,"twenty":-4.453178,"median":1.602824,"eighty":6.064803,"marketCap":435628857},{"date":"2024-11-22","current":-12.242757,"twenty":-4.500185,"median":1.585373,"eighty":6.064803,"marketCap":460251357},{"date":"2024-11-29","current":105.02825,"twenty":-4.500185,"median":1.585373,"eighty":6.132491,"marketCap":594728092},{"date":"2024-12-06","current":101.226386,"twenty":-4.500185,"median":1.585373,"eighty":6.322232,"marketCap":571999630},{"date":"2024-12-13","current":98.989053,"twenty":-4.500185,"median":1.585373,"eighty":7.397105,"marketCap":558741360},{"date":"2024-12-20","current":85.236807,"twenty":-4.500185,"median":1.585373,"eighty":8.248611,"marketCap":479191743},{"date":"2024-12-27","current":98.062015,"twenty":-4.500185,"median":1.585373,"eighty":8.459218,"marketCap":551165206},{"date":"2025-01-03","current":94.372016,"twenty":-4.500185,"median":1.585373,"eighty":8.718047,"marketCap":530330782},{"date":"2025-01-10","current":92.424911,"twenty":-4.501898,"median":1.584133,"eighty":8.928773,"marketCap":517072513},{"date":"2025-01-17","current":91.747806,"twenty":-4.501898,"median":1.584488,"eighty":9.39695,"marketCap":513284436},{"date":"2025-01-24","current":98.596639,"twenty":-4.501898,"median":1.601225,"eighty":9.783586,"marketCap":554953283},{"date":"2025-01-31","current":99.438002,"twenty":-4.501898,"median":1.613843,"eighty":10.562535,"marketCap":562529437},{"date":"2025-02-07","current":99.950895,"twenty":-4.501898,"median":1.625636,"eighty":11.383302,"marketCap":562529437},{"date":"2025-02-14","current":100.350725,"twenty":-4.501898,"median":1.641046,"eighty":12.297388,"marketCap":564423475},{"date":"2025-02-21","current":107.205077,"twenty":-4.501898,"median":1.647915,"eighty":12.677797,"marketCap":606092323},{"date":"2025-02-28","current":94.118612,"twenty":-4.501898,"median":1.664456,"eighty":14.155737,"marketCap":530330782},{"date":"2025-03-07","current":91.684274,"twenty":-4.50361,"median":1.691225,"eighty":14.495249,"marketCap":518966551},{"date":"2025-03-14","current":90.651653,"twenty":-4.50361,"median":1.724908,"eighty":15.427996,"marketCap":513284436},{"date":"2025-03-21","current":96.715498,"twenty":-4.50361,"median":1.734885,"eighty":15.679813,"marketCap":547377129},{"date":"2025-03-28","current":89.912948,"twenty":-4.50361,"median":1.752834,"eighty":15.814795,"marketCap":507602320},{"date":"2025-04-04","current":88.086277,"twenty":-4.50361,"median":1.851142,"eighty":15.971694,"marketCap":496238089},{"date":"2025-04-11","current":77.337205,"twenty":-4.501898,"median":1.906636,"eighty":16.218055,"marketCap":433734818},{"date":"2025-04-17","current":82.909148,"twenty":-4.501898,"median":1.979101,"eighty":16.305595,"marketCap":465933473},{"date":"2025-04-25","current":39.881609,"twenty":-4.50361,"median":2.047379,"eighty":16.523356,"marketCap":501920205},{"date":"2025-04-30","current":35.734802,"twenty":-4.50361,"median":2.083522,"eighty":16.552549,"marketCap":450795323}],"updateTime":1746101791213}}}